Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1183/09059180.00002009 | DOI Listing |
BMJ Case Rep
October 2024
Tallahassee Memorial HealthCare, Tallahassee, Florida, USA.
Multidiscip Respir Med
February 2024
Department of Internal Medicine, Pulmonology Service, Fundación Valle del Lili, Cali, Colombia.
Introduction: Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients.
Case Presentation: We described six patients who were admitted to the ICU for NFA and received ECMO treatment at a high-complexity institution in Cali, Colombia, between 2015 and 2019.
Front Cardiovasc Med
February 2024
Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Introduction: Immune checkpoint inhibitors have advanced the outcomes of many different types of cancer. A rare but extraordinarily severe complication of these agents resembles immune checkpoint inhibitor-related myocarditis, which typically occurs within the first few weeks after treatment initiation with a mortality of 25%-50%.
Case Report: A 57-year-old woman had uneventfully received pembrolizumab for metastatic non-small cell lung cancer for over 2.
J Asthma
August 2024
Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, China.
Background: Fatal asthma is a rapidly progressing and highly fatal form of asthma. Mechanical ventilation, although necessary for respiratory support, can exacerbate the condition and lead to ventilator-associated lung injury. ECMO therapy is crucial in allowing the lungs to rest and recover, as it provides extracorporeal membrane oxygenation.
View Article and Find Full Text PDFRespir Med Case Rep
December 2023
Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, PA, USA.
Near-fatal asthma (NFA) is the most severe presentation of asthma. It is characterized by hypoxemic and hypercapnic respiratory failure requiring ventilatory assistance, including non-invasive ventilation and mechanical ventilation. However, NFA has a high mortality rate despite conventional therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!